title: Reevaluation of antibody titers 1 year after influenza vaccination in patients with rheumatoid arthritis receiving TNF blockers.
authors.forename: Tokiko
authors.initials: T
authors.lastname: Nii
authors.forename: Tetsuo
authors.initials: T
authors.lastname: Kubota
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Nanki
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Komano
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Harigai
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Kohsaka
authors.forename: Wataru
authors.initials: W
authors.lastname: Hirose
authors.forename: Kenji
authors.initials: K
authors.lastname: Nagasaka
authors.forename: Tetsushi
authors.initials: T
authors.lastname: Sakurai
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Miyasaka
mesh_terms: D000914:Antibodies, Viral / Q000097:blood*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D053122:Influenza A Virus, H3N2 Subtype / Q000276:immunology; D007252:Influenza Vaccines / Q000276:immunology* / Q000627:therapeutic use; D007564:Japan; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000914:Antibodies, Viral; D007252:Influenza Vaccines; D014409:Tumor Necrosis Factor-alpha